Active ingredientLanreotideCat. No. P-L014-001CAS 108736-35-2Family · Pharmaceutical analytical standards
Lanreotide
A long-acting synthetic analogue of somatostatin, the hormone that curbs the secretion of growth hormone: it is used for acromegaly and neuroendocrine tumours. It was approved in the US in 2007. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?In water it spontaneously self-assembles into identical nanotubes, 24.4 nanometres in diameter: behaviour so regular that it has become a model system in biophysics studies.
Go to the active ingredient →Active ingredientLanreotideCat. No. P-L014-001CAS 108736-35-2
Isotopically labelledLanreotide-d8Cat. No. P-L014-002
NitrosamineN-Nitroso LanreotideCat. No. P-L014-003
ImpurityLanreotide DitrifluoroacetateCat. No. P-L014-004
ImpurityLanreotide Impurity 1Cat. No. P-L014-005
ImpurityLanreotide Impurity 2Cat. No. P-L014-006
ImpurityLanreotide Impurity 3Cat. No. P-L014-007
ImpurityLanreotide Impurity 4Cat. No. P-L014-008
ImpurityLanreotide Impurity 5Cat. No. P-L014-010
ImpurityLanreotide Impurity 6Cat. No. P-L014-015
ImpurityLanreotide Impurity 7Cat. No. P-L014-016No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.